A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

The goal of this study is to find out whether different formulations of survodutide given by different delivery methods is taken up in the body in a similar way. Participants visit the study site regularly. During study visits, the doctors collect information about participants' health. To assess the study endpoints, participants regularly have blood samples taken.

NCT Number	NCT07413913
Lead Sponsor	Boehringer Ingelheim
Conditions	Healthy, Obesity
Enrollment	56 participants
Start Date	2026-03-03
Primary Completion	2026-05-28 (estimated)
Study Completion	2026-06-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-15